Peter Wilver
LivaNovaAbout Peter Wilver
Independent director of LivaNova PLC (LIVN); age 65; director since 2022. Former EVP & Chief Administrative Officer and previously SVP & CFO of Thermo Fisher Scientific; earlier finance leadership roles at Thermo Electron, Honeywell, Grimes Aerospace, and GE. He holds a BS in Accounting from The Ohio State University and is a certified public accountant; identified as an audit committee financial expert.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Thermo Fisher Scientific Inc. | EVP & Chief Administrative Officer | Aug 2015 – Mar 2017 | Senior corporate leader across admin functions; strategy execution |
| Thermo Fisher Scientific Inc. | SVP & Chief Financial Officer | Nov 2006 – Jul 2015 | Public company CFO; financial reporting, IR, strategic planning |
| Thermo Electron | VP & CFO | 2004 – 2006 | Corporate finance leadership |
| Thermo Electron | VP, Financial Operations | 2000 – 2004 | Financial operations leadership |
| Honeywell; Grimes Aerospace; GE | Finance leadership roles | Prior to 2000 | Progressive finance roles |
External Roles
| Organization | Role | Status / Timing | Notes |
|---|---|---|---|
| Baxter International Inc. (BAX) | Director | Former; within past five years | Disclosed as former public company directorship in last 5 years |
| CIRCOR International, Inc. (CIR) | Director | Former; within past five years | Disclosed as former public company directorship in last 5 years |
| Evoqua Water Technologies Corp. (AQUA) | Director | Former; within past five years | Disclosed as former public company directorship in last 5 years |
| Shoals Technologies Group, Inc. (SHLS) | Director | Former; within past five years | Disclosed as former public company directorship in last 5 years |
Board Governance
- Committee assignments: Audit & Compliance Committee (member); Compensation & Human Capital Management Committee (member). Not a committee chair.
- Audit committee financial expert; all Audit & Compliance Committee members meet SEC “audit committee financial expert” criteria and heightened independence standards.
- Independence: Board determined all directors other than the CEO are independent; Wilver is independent.
- Attendance and engagement: Board met 9 times in 2024; each director attended at least 75% of Board and respective committee meetings. AC held 8 scheduled meetings; CHCM held 11.
- Executive sessions: Regular executive sessions of independent directors at Board and committee meetings.
- Risk oversight: AC oversees financial reporting, internal controls, compliance, and cybersecurity risk processes.
Fixed Compensation
| Component | 2024 Amount/Term | Notes |
|---|---|---|
| Cash fees (Wilver) | $105,390 | Fees earned in cash for 2024 |
| Equity grant (Wilver) | $180,000 (RSUs) | 3,416 RSUs; service-based |
| Total (Wilver) | $285,390 | Sum of cash + RSUs fair value |
| Board retainer (pre-2024 AGM) | $110,000 (non-exec); $185,000 (Chair) | Cash retainer effective Jan 2024 until 2024 AGM |
| Committee chair fees (annual) | $30,000 (AC); $20,000 (CHCM); $20,000 (NCG) | 2024 structure |
| Committee member fees (annual) | $15,000 (AC); $8,000 (CHCM); $8,000 (NCG) | 2024 structure |
| Board retainer (post-2024 AGM) | $60,000 (non-exec); $135,000 (Chair) | Cash retainer reduced to shift mix toward equity |
| 2025 changes (effective at 2025 AGM) | Cash retainer +$10k (to $70k non-exec; $145k Chair) | Member fees +$2k for NCG/CHCM; equity grant +$5k (to $185k; $260k Chair) |
Performance Compensation
| Equity Vehicle | Grant Value / Units | Vesting / Triggers | Performance Metrics |
|---|---|---|---|
| Service-based RSUs (Director annual grant) | $180,000; 3,416 RSUs (Wilver, 2024) | Vest on earlier of 1-year anniversary of grant or date of Change in Control | None (service-based; directors) |
| Equity mix shift | $180k standard; Chair $255k (2024), $260k (2025 plan) | Aligns with decreased cash retainer post-2024 AGM | Not performance-based for directors |
LivaNova notes double-trigger vesting for equity awards granted after Feb 15, 2023 generally, but director RSUs vest on the earlier of one year or change in control per the director table footnote.
Other Directorships & Interlocks
- Current other public company boards: None disclosed for Wilver.
- CHCM interlocks: Company discloses no compensation committee interlocks in 2024.
Expertise & Qualifications
- CPA and former public-company CFO; deep expertise in financial reporting, investor relations, strategic planning, business development, compensation planning, and strategy execution; designated audit committee financial expert.
Equity Ownership
| As of April 14, 2025 | Shares Owned | Shares Acquirable within 60 days | Total Beneficial Ownership | % of Class |
|---|---|---|---|---|
| Peter Wilver | 3,732 | 3,416 | 7,148 | * (<1%) |
- Stock ownership guidelines: Non-executive directors must hold equity equal to 5x the annual cash retainer; until met, must retain 100% of net shares from company equity awards. Prohibitions on hedging and pledging apply to directors.
Governance Assessment
- Strengths: Independent director; audit committee financial expert; heavy committee workload (AC and CHCM) with robust meeting cadence; director equity is majority of pay (approx. 63% of Wilver’s 2024 total), aligning incentives with shareholders; anti-hedging/pledging policies; strong say-on-pay support (95% in 2024), signaling shareholder confidence in overall governance.
- Compensation structure signals: 2024 cash retainer reduced with offsetting increase in RSUs; 2025 minor increases maintain equity-heavy mix—generally positive for alignment without excessive guaranteed cash.
- Conflicts/related party risk: Company reports no related party transactions in 2024; CHCM interlocks none.
- Attendance/engagement: Each director attended at least 75% of Board/committee meetings; Wilver serves on two high-intensity committees (AC: 8 meetings; CHCM: 11 meetings), indicating material engagement.
- Potential red flags: None identified—no pledging/hedging allowed; no related-party transactions disclosed; director equity is service-based rather than performance-based, which is standard for non-exec directors.